Bridges Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$597K Hold
7,067
0.33% 75
2017
Q3
$605K Sell
7,067
-2,066
-23% -$169K 0.34% 73
2017
Q2
$751K Buy
+9,133
New +$745K 0.17% 101
2017
Q1
Sell
-9,133
Closed -$672K 134
2016
Q4
$672K Hold
9,133
0.16% 102
2016
Q3
$733K Hold
9,133
0.15% 99
2016
Q2
$719K Hold
9,133
0.16% 103
2016
Q1
$657K Buy
+9,133
New +$691K 0.14% 104
2015
Q3
Sell
-8,933
Closed -$746K 151
2015
Q2
$746K Sell
8,933
-200
-2% -$15.2K 0.18% 106
2015
Q1
$664K Hold
9,133
0.15% 112
2014
Q4
$630K Hold
9,133
0.14% 114
2014
Q3
$592K Sell
9,133
-300
-3% -$19K 0.14% 112
2014
Q2
$587K Hold
9,433
0.13% 119
2014
Q1
$555K Sell
9,433
-150
-2% -$8.37K 0.13% 115
2013
Q4
$489K Sell
9,583
-1,100
-10% -$55.1K 0.11% 121
2013
Q3
$538K Hold
10,683
0.13% 117
2013
Q2
$525K Buy
+10,683
New +$581K 0.13% 115

Other funds holding LLY

Bridges Investment Counsel's LLY Position: Q4 2017 in Review

Bridges Investment Counsel held its Eli Lilly (LLY) position steady in Q4 2017 at 7,067 shares worth $597K. The position accounts for 0.33% of the portfolio, ranked #75.

Bridges Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 16 quarters since. The position peaked at $751K in Q2 2017. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • Bridges Investment Counsel held 7,067 shares of Eli Lilly worth $597K as of Q4 2017.
  • Bridges Investment Counsel left its Eli Lilly share count unchanged in Q4 2017.
  • Eli Lilly made up 0.33% of Bridges Investment Counsel's portfolio in Q4 2017, its #75 holding.
  • Bridges Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 16 quarters since.
  • Bridges Investment Counsel's Eli Lilly position peaked at $751K in Q2 2017.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.